Levendowski Daniel J, Ferini-Strambi Luigi, Gamaldo Charlene, Cetel Mindy, Rosenberg Robert, Westbrook Philip R
Advanced Brain Monitoring, Carlsbad, California.
Department of Clinical Neurosciences, San Raffaele Scientific Institute, Sleep Disorders Center, Università Vita-Salute San Raffaele, Milan, Italy.
J Clin Sleep Med. 2017 Jun 15;13(6):791-803. doi: 10.5664/jcsm.6618.
To assess the validity of sleep architecture and sleep continuity biomarkers obtained from a portable, multichannel forehead electroencephalography (EEG) recorder.
Forty-seven subjects simultaneously underwent polysomnography (PSG) while wearing a multichannel frontopolar EEG recording device (Sleep Profiler). The PSG recordings independently staged by 5 registered polysomnographic technologists were compared for agreement with the autoscored sleep EEG before and after expert review. To assess the night-to-night variability and first night bias, 2 nights of self-applied, in-home EEG recordings obtained from a clinical cohort of 63 patients were used (41% with a diagnosis of insomnia/depression, 35% with insomnia/obstructive sleep apnea, and 17.5% with all three). The between-night stability of abnormal sleep biomarkers was determined by comparing each night's data to normative reference values.
The mean overall interscorer agreements between the 5 technologists were 75.9%, and the mean kappa score was 0.70. After visual review, the mean kappa score between the autostaging and five raters was 0.67, and staging agreed with a majority of scorers in at least 80% of the epochs for all stages except stage N1. Sleep spindles, autonomic activation, and stage N3 exhibited the least between-night variability ( < .0001) and strongest between-night stability. Antihypertensive medications were found to have a significant effect on sleep quality biomarkers ( < .02).
A strong agreement was observed between the automated sleep staging and human-scored PSG. One night's recording appeared sufficient to characterize abnormal slow wave sleep, sleep spindle activity, and heart rate variability in patients, but a 2-night average improved the assessment of all other sleep biomarkers.
Two commentaries on this article appear in this issue on pages 771 and 773.
评估通过便携式多通道前额脑电图(EEG)记录仪获得的睡眠结构和睡眠连续性生物标志物的有效性。
47名受试者在佩戴多通道额极EEG记录设备(睡眠分析仪)的同时接受多导睡眠图(PSG)检查。由5名注册多导睡眠图技术人员独立进行分期的PSG记录,与专家审查前后自动评分的睡眠EEG进行一致性比较。为了评估夜间变异性和首夜效应,使用了从63例患者的临床队列中获得的两晚自我在家进行的EEG记录(41%诊断为失眠/抑郁症,35%患有失眠/阻塞性睡眠呼吸暂停,17.5%患有所有三种疾病)。通过将每晚的数据与正常参考值进行比较,确定异常睡眠生物标志物的夜间稳定性。
5名技术人员之间的平均总体评分者间一致性为75.9%,平均kappa评分为0.70。经过视觉审查后,自动分期与5名评分者之间的平均kappa评分为0.67,除N1期外,所有阶段至少80%的时段分期与大多数评分者一致。睡眠纺锤波、自主神经激活和N3期表现出最小的夜间变异性(<0.0001)和最强的夜间稳定性。发现抗高血压药物对睡眠质量生物标志物有显著影响(<0.02)。
自动睡眠分期与人工评分的PSG之间观察到高度一致性。一晚的记录似乎足以表征患者异常的慢波睡眠、睡眠纺锤波活动和心率变异性,但两晚的平均值改善了所有其他睡眠生物标志物的评估。
本期第771页和773页有两篇关于本文的评论。